AdaptHealth Target of Unusually High Options Trading (NASDAQ:AHCO)

AdaptHealth Corp. (NASDAQ:AHCO) was the recipient of unusually large options trading activity on Thursday. Stock traders acquired 41,622 put options on the stock. This represents an increase of approximately 1,002% compared to the typical volume of 3,777 put options.

AdaptHealth Trading Up 1.6 %

Shares of AHCO stock traded up $0.17 during trading on Thursday, hitting $10.80. 156,603 shares of the stock traded hands, compared to its average volume of 808,247. The firm has a market capitalization of $1.45 billion, a P/E ratio of -6.54, a price-to-earnings-growth ratio of 1.32 and a beta of 1.09. AdaptHealth has a 52-week low of $6.91 and a 52-week high of $11.90. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00. The firm’s fifty day moving average price is $9.98 and its 200-day moving average price is $10.38.

AdaptHealth (NASDAQ:AHCO) last released its quarterly earnings results on Tuesday, November 5th. The company reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.02). The business had revenue of $805.90 million for the quarter, compared to analysts’ expectations of $809.32 million. AdaptHealth had a positive return on equity of 9.62% and a negative net margin of 6.57%. The business’s revenue for the quarter was up .2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.19 earnings per share. As a group, research analysts forecast that AdaptHealth will post 0.88 earnings per share for the current fiscal year.

Institutional Investors Weigh In On AdaptHealth

Institutional investors and hedge funds have recently made changes to their positions in the stock. Blue Trust Inc. raised its position in AdaptHealth by 24.1% in the fourth quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock valued at $55,000 after purchasing an additional 1,115 shares during the period. Quarry LP raised its holdings in shares of AdaptHealth by 4,596.9% in the 3rd quarter. Quarry LP now owns 5,965 shares of the company’s stock valued at $67,000 after buying an additional 5,838 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its stake in AdaptHealth by 15.4% during the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock worth $121,000 after acquiring an additional 1,690 shares in the last quarter. CIBC Asset Management Inc purchased a new position in AdaptHealth during the 3rd quarter valued at about $122,000. Finally, MBB Public Markets I LLC acquired a new position in AdaptHealth in the 2nd quarter valued at about $142,000. 82.67% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

AHCO has been the subject of several research reports. Canaccord Genuity Group dropped their price target on AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a research report on Wednesday, November 6th. Robert W. Baird decreased their price target on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 6th. UBS Group decreased their target price on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a research note on Wednesday, November 6th. Truist Financial cut their price target on AdaptHealth from $13.00 to $12.00 and set a “buy” rating for the company in a report on Friday, November 15th. Finally, Royal Bank of Canada lowered their price objective on AdaptHealth from $13.00 to $11.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 19th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat, AdaptHealth presently has an average rating of “Buy” and a consensus target price of $12.40.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.